A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
Stephen L. Chan, Martin Schuler, Yoon Koo Kang, Chia Jui Yen, Julien Edeline, Su Pin Choo, Chia Chi Lin, Takuji Okusaka, Karl Heinz Weiss, Teresa Macarulla, Stéphane Cattan, Jean Frederic Blanc, Kyung Hun Lee, Michela Maur, Shubham Pant, Masatoshi Kudo, Eric Assenat, Andrew X. Zhu, Thomas Yau, Ho Yeong Lim
研究成果: Article › 同行評審
3
引文
斯高帕斯（Scopus）